Additional funding awarded to Cancer Drugs Fund: Macmillan response
Macmillan cancer support response to the extension of the Cancer Drugs Fund
Responding to the Prime Minister David Cameron’s announcement that the Cancer Drugs Fund will receive additional funding of £400million to extend it until March 2016, Mike Hobday, Director of Policy & Research at Macmillan Cancer Support, says:
“We are delighted that the Government has decided to extend the Cancer Drugs Fund by a further two years. In 2010, we campaigned to secure this funding so that more cancer patients would be able to access life-prolonging and vital treatment.
“Since then, tens of thousands of people have been able to get the most effective cancer drugs no matter where they are from or which cancer they have. Today’s announcement means that many more can be helped.
“However the Government must ensure that all drugs available through the fund will be available through the NHS after 2016. We have to avoid a return to the bad old days when cancer patients were denied lifesaving drugs simply because of where they lived or that they had a rarer cancer.”